UK markets open in 2 hours 2 minutes
NIKKEI 225
38,198.13 +124.15 (+0.33%) HANG SENG
18,859.60 +321.79 (+1.74%) CRUDE OIL
79.80 +0.54 (+0.68%) GOLD FUTURES
2,360.20 +19.90 (+0.85%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
50,256.76 +1,120.68 (+2.28%)
Shanghai Junshi Biosciences Co., Ltd. (8SJ.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 3.42B |
| Enterprise value | 3.20B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.92 |
| Price/book (mrq) | 1.65 |
| Enterprise value/revenue | 15.06 |
| Enterprise value/EBITDA | -3.29 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.36 |
| 52-week change 3 | -53.12% |
| S&P500 52-week change 3 | 26.43% |
| 52-week high 3 | 3.3200 |
| 52-week low 3 | 1.0600 |
| 50-day moving average 3 | 1.2706 |
| 200-day moving average 3 | 2.0043 |
Share statistics
| Avg vol (3-month) 3 | 25 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 219.3M |
| Implied shares outstanding 6 | 2.28B |
| Float 8 | 671.18M |
| % held by insiders 1 | 22.43% |
| % held by institutions 1 | 22.82% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -124.25% |
| Operating margin (ttm) | -84.41% |
Management effectiveness
| Return on assets (ttm) | -11.32% |
| Return on equity (ttm) | -26.95% |
Income statement
| Revenue (ttm) | 1.63B |
| Revenue per share (ttm) | 1.66 |
| Quarterly revenue growth (yoy) | 49.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -1.92B |
| Net income avi to common (ttm) | -2.02B |
| Diluted EPS (ttm) | -0.2700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.56B |
| Total cash per share (mrq) | 4.67 |
| Total debt (mrq) | 3.03B |
| Total debt/equity (mrq) | 43.16% |
| Current ratio (mrq) | 2.09 |
| Book value per share (mrq) | 7.03 |
Cash flow statement
| Operating cash flow (ttm) | -1.66B |
| Levered free cash flow (ttm) | -1.9B |
© 2024 Yahoo. All rights reserved.